NCT07601516 Real World Effectiveness and Safety of Deutetrabenazine in Adult Chinese Patients With Huntington's Disease (HD) Chorea in China Status COMPLETED Phase PHASE4
NCT07536061 A First-in-human Study of the Effects of SRP-1005 in Participants With Huntington's Disease Status NOT_YET_RECRUITING Phase PHASE1
NCT07246941 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RG6496 in Huntington's Disease Status RECRUITING Phase PHASE1
NCT06634628 iMagemHTT-009- FIH Evaluation of Novel Mutant Huntingtin PET Radioligand [11C]CHDI-00491009 Status RECRUITING Phase EARLY_PHASE1
NCT06585449 A Study to Evaluate ALN-HTT02 in Adult Patients With Huntington's Disease Status RECRUITING Phase PHASE1
NCT05655520 A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Huntington's Disease Status TERMINATED Phase PHASE3
NCT05107128 A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease (HD) Status COMPLETED Phase PHASE2
NCT04120493 Safety and Proof-of-Concept (POC) Study With AMT-130 in Adults With Early Manifest Huntington's Disease Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03664804 Study to Measure Cerebrospinal Fluid Mutant Huntingtin Protein in Participants With Early Manifest Stage I or Stage II Huntington's Disease Status COMPLETED Phase PHASE1
NCT03628235 HD-Charge: Indirect and Out-of-Pocket Costs of Huntington's Disease in the United States Status COMPLETED Phase N/A
NCT03342053 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7234292 (ISIS 443139) in Huntington's Disease Patients Who Participated in Prior Investigational Studies of RO7234292 (ISIS 443139) Status COMPLETED Phase PHASE2
NCT03306888 Feasibility and Acceptability of Implementing a Clinic-based Physical Activity Coaching Intervention in People With Premanifest and Early Stage HD Status COMPLETED Phase PHASE1/PHASE2
NCT03225846 Safety and Tolerability of WVE-120102 in Patients With Huntington's Disease Status TERMINATED Phase PHASE1/PHASE2
NCT03225833 Safety and Tolerability of WVE-120101 in Patients With Huntington's Disease Status TERMINATED Phase PHASE1/PHASE2
NCT02990676 Exploring Computerised Cognitive Training for People With Huntington's Disease Status COMPLETED Phase NA
NCT02956148 Follow-up Measurement of Brain PDE10A Enzyme Levels in Huntington´s Disease Gene Expansion Carriers Status COMPLETED Phase EARLY_PHASE1
NCT02855476 HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease Status RECRUITING Phase N/A
NCT02750982 Laughter Therapy Effects on Mood, Stress and Self-efficacy in People With Neurological Diseases. Status COMPLETED Phase NA